VRDN — VIRIDIAN THERAPEUTICS INC

Ownership history in Elmind Capital, LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which Elmind Capital, LP reported a position in VIRIDIAN THERAPEUTICS INC (VRDN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
7.89% (2025 Q4)
Avg. % of fund
7.89%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 858,631 — — 7.89% $26.7M $31.12
% of Fund (quarterly)    VRDN price (monthly, adj. close)

Other funds also holding VRDN

As of 2025 Q4 — sorted by position size

Fairmount Funds Management LLC 3Y 9.27% Propel Bio Management, LLC 7.51% 5AM Venture Management, LLC 3Y 7.21% VR Adviser, LLC 3Y 5.97% Novo Holdings A/S 3Y 7Y 5.75% Rosalind Advisors, Inc. 4.92% Kopp Family Office, LLC 3Y 3.44% HighVista Strategies LLC 3Y 7Y 2.99% Kynam Capital Management, LP 3Y 2.92% Eversept Partners, LP 3Y 7Y 2.79%
← Back to Elmind Capital, LP Holdings